hr 2883Bill

Stop Stalling Access to Affordable Medications

To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.

Introduced on April 28, 2021

House
Senate
President